123 related articles for article (PubMed ID: 386320)
1. Detection of antidonor antibody: advantages of fibroblast target cells.
Halloran PF; Aprile M; Haddad G; Robinette M
Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():49-55. PubMed ID: 386320
[TBL] [Abstract][Full Text] [Related]
2. Donor-specific antibodies in renal allograft recipients. A reevaluation of the 51Cr-release assays comparing fibroblast and lymphoid target cells.
Halloran PF; Aprile M; Haddad G; Cunningham K; Robinette MA
Transplantation; 1984 Apr; 37(4):356-8. PubMed ID: 6369664
[TBL] [Abstract][Full Text] [Related]
3. Anti-donor immune responses in prediction of transplant rejection.
Stiller CR; StC Sinclair NR; Abrahams S; McGirr D; Singh H; Howson WT; Ulan RA
N Engl J Med; 1976 Apr; 294(18):978-82. PubMed ID: 130555
[TBL] [Abstract][Full Text] [Related]
4. Effect of alloantibodies on corneal allograft survival.
Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
[TBL] [Abstract][Full Text] [Related]
5. The correlation of kidney transplant survival with lymphocyte mediated cytotoxicity on B cell targets.
Nathan P; Plessinger RT; First MR
Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():62-7. PubMed ID: 386322
[TBL] [Abstract][Full Text] [Related]
6. Alloantibodies and outcomes of deceased donor kidney allografts.
Cinti P; Pretagostini R; Lai Q; Tamburro ML; Rossi M; Poli L; Berloco P
Hum Immunol; 2009 Aug; 70(8):651-4. PubMed ID: 19527761
[TBL] [Abstract][Full Text] [Related]
7. Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection.
Mayer TG; Fuller AA; Fuller TC; Lazarovits AI; Boyle LA; Kurnick JT
J Immunol; 1985 Jan; 134(1):258-64. PubMed ID: 3155462
[TBL] [Abstract][Full Text] [Related]
8. Adverse presensitization to renal transplants. Detection by utilization of a D locus antigen-defined lymphoblastoid cell panel as targets in antibody-dependent cell-mediated cytotoxicity assays.
Suthanthiran M; Fotino M; Cheigh JS; Rubin AL; Novogrodsky A; Stenzel KH
Transplantation; 1979 May; 27(5):333-7. PubMed ID: 373190
[TBL] [Abstract][Full Text] [Related]
9. Autoantibody against fibroblasts in renal transplant recipients: analysis by 51Cr-release assays.
Aprile M; Halloran P; Haddad G; Robinette M
Clin Exp Immunol; 1981 Dec; 46(3):565-74. PubMed ID: 7039893
[TBL] [Abstract][Full Text] [Related]
10. Assessment of whole blood for antibody-dependent cell-mediated cytotoxicity in kidney patients.
Dupont E
Proc Eur Dial Transplant Assoc; 1977; 14():321-7. PubMed ID: 341133
[TBL] [Abstract][Full Text] [Related]
11. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
12. Pretransplant assays of alloimmunity in predicting renal graft outcome.
Gailiunas P; Person A; Suthanthiran M; Carpenter CB; Garovoy MR
Proc Clin Dial Transplant Forum; 1977; 7():1-3. PubMed ID: 356029
[TBL] [Abstract][Full Text] [Related]
13. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
14. The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody.
Halloran PF; Schlaut J; Solez K; Srinivasa NS
Transplantation; 1992 Mar; 53(3):550-5. PubMed ID: 1549846
[TBL] [Abstract][Full Text] [Related]
15. Donor-specific cell-mediated cytotoxicity in renal allograft recipients.
Dickmeiss E
Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):371-76. PubMed ID: 397716
[TBL] [Abstract][Full Text] [Related]
16. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA
Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518
[TBL] [Abstract][Full Text] [Related]
17. In vitro cytotoxicity by human lymphocytes from individuals immunized against histocompatibility antigens. II. Relation to HL-A incompatibility between effector and target cells.
Lundgren G; Möller E; Thorsby E
Clin Exp Immunol; 1970 May; 6(5):671-80. PubMed ID: 4920602
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of immunosuppression by antilymphocyte antibody.
Taub RN
Pathobiol Annu; 1972; 2():129-51. PubMed ID: 4149315
[No Abstract] [Full Text] [Related]
19. Loss of tolerance to a maternal kidney transplant is selective for HLA class II: evidence from trans-vivo DTH and alloantibody analysis.
Burlingham WJ; Jankowska-Gan E; VanBuskirk A; Orosz CG; Lee JH; Kusaka S
Hum Immunol; 2000 Dec; 61(12):1395-402. PubMed ID: 11163098
[TBL] [Abstract][Full Text] [Related]
20. Alloantibodies and the outcome of cadaver kidney allografts.
Vasilescu ER; Ho EK; Colovai AI; Vlad G; Foca-Rodi A; Markowitz GS; D'Agati V; Hardy MA; Ratner LE; Suciu-Foca N
Hum Immunol; 2006 Aug; 67(8):597-604. PubMed ID: 16916655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
